Evidence map›Paper›PMID 38028320›Full record

ArticleEnvironment & health (Washington, D.C.)2023

Differential Toxicity of Electronic Cigarette Aerosols Generated from Different Generations of Devices

Tiancong Ma, Haoxuan Chen, Yu-Pei Liao, Jiulong Li, Xiang Wang, Liqiao Li, Jing Li, Yifang Zhu, Tian Xia

Open access · diamondAbstract read
In one paragraph

Article in Environment & health (Washington, D.C.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Inhibition of Circadian Rhythm GeneEnvironment & health (Washington, D.C.) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tiancong MaDivision of Nanomedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0003-0663-7021
Haoxuan ChenDepartment of Environmental Health Sciences, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0001-8398-9093
Yu-Pei LiaoDivision of Nanomedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0001-7239-9426
Jiulong LiDivision of Nanomedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0002-8816-7539
Xiang WangDivision of Nanomedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0002-6647-0684
Liqiao LiDepartment of Environmental Health Sciences, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0002-8873-1275
Jing LiDepartment of Environmental Health Sciences, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0003-0639-9422
Yifang ZhuDepartment of Environmental Health Sciences, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0002-0591-3322
Tian XiaDivision of Nanomedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095-1772, United States.ORCID https://orcid.org/0000-0003-0123-1305
University of California, Los Angeles · US

Funding

Linking E-Cigarette Aerosol Characteristics to Mechanisms of Pulmonary ToxicityR01HL139379 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHU, YIFANG · 2018 to 2021
$1.8M
NHLBI NIH HHS R01 HL139379
6 · The paper itself

Abstract

Electronic cigarettes (e-cigs) have become increasingly popular, especially among youth, raising concerns about their potential health risks. JUUL and Tank devices are two common types of e-cigs that deliver aerosols with varying nicotine levels and flavors. However, the differences in the aerosols generated from different devices and their corresponding cytotoxicity and pulmonary injury effects remain poorly understood. This study addresses these knowledge gaps by characterizing the aerosols of JUUL and Tank e-cig devices and testing their toxic effects on THP-1 and BEAS-2B human cell lines as well as the C57BL/6J mouse model. In our study, the lower-voltage device, the 3.7 V JUUL generates 2.72 mg/puff aerosols by using e-liquid containing 3% nicotine salt (i.e., nicotine benzoate), which is less than the 11.06 mg/puff aerosols generated by the 7.5 V Tank using e-liquid containing 2.4% freebase nicotine. Yet, the cytotoxicity results reveal that JUUL aerosols induced higher toxicity and increased production of pro-inflammation cytokines compared to Tank aerosols per puff. Additionally, we observed that JUUL induced more severe pulmonary inflammation and DNA damage compared to Tank after normalizing for cotinine, a nicotine metabolite,

Identifiers

PMID38028320
PMCPMC10660664
OpenAlexW4386471138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.